Qiagen, Ventana Settle IP Litigation | GenomeWeb
NEW YORK (GenomeWeb News) – Qiagen and Ventana Medical Systems jointly announced today that they have agreed to settle litigation regarding two expired patents covering human papillomavirus probes.
The firms said that they had mutually agreed to terms on Dec. 15 settling litigation of the expired patents, US Nos. 4,849,331 and 4,849,332.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.